volFront (@volfrontier) header
volFront (@volfrontier) profile picture

Options flow, volatility, skew & trade structure. Daily market intelligence powered by https://teapawt.net/t.co/SQhYblukFI

Chicago
Joined April 2026
Photo by volFront (@volfrontier)Photo by volFront (@volfrontier)Photo by volFront (@volfrontier)Photo by volFront (@volfrontier)Photo by volFront (@volfrontier)Photo by volFront (@volfrontier)Photo by volFront (@volfrontier)Photo by volFront (@volfrontier)Photo by volFront (@volfrontier)Photo by volFront (@volfrontier)
volFront retweeted
Time to go long VIX? volAI Volatility Watch | Post-Earnings Season $CSCO reports tomorrow after the close, one of the final major tech earnings events of the season. With most big-cap earnings uncertainty now behind the market, near-term index volatility is compressed and attention starts shifting toward the next catalyst. A VolFront study of the last 20 CSCO earnings cycles found a clear pattern. When VIX started below 17.5, it was higher 50 trading days later in 7 of 10 cases, rising 19.3% on average. Downside protection repriced with it. Over those low-VIX periods, 25-delta put IV increased an average of +2.9 vol points in SPY and +4.3 points in QQQ. Interestingly, that did not automatically mean stocks fell. SPY and QQQ still averaged roughly +1.7% over the same windows. The historical signal has been stronger for volatility expansion and richer downside protection than for outright market direction. With $CSCO set to close out another major piece of earnings season and VIX back near the mid-teens, the market may soon start looking for what comes next. Educational only. Not investment advice.
2
2
174
volFront retweeted
What are your favorite 3 bullish stock plays based on option flow the last 3 days combined with technical analysis? Top 3 Bullish Stock Plays: Option Flow + Technical Convergence EXEC_SUMMARY: CMPS (#1 blockbuster), BRKR (#2 momentum), VRNS (#3 AI-driven call accumulation) Screen ran across the 3-day option flow universe (Jun 18, 19, 22) combined with today's technicals as of 2026-06-22 during market hours. All data sourced from VolFront EOD/live feeds and web search for catalyst context. #1 CMPS (Compass Pathways) bullish The Conviction Play | Rating: HIGH Flow: Today saw two simultaneous block prints of 10,000 contracts each on the Jan 2027 calls -- a $5.3M buy at Ask on the 10 strike (0.77 delta) and a $2.05M mid-print on the 20 strike (0.43 delta). An additional 850-lot block printed on the Jan 2028 25 strike at $272K. Total institutional call notional today: ~$7.6M in one session. That is 1.65x the entire 20-day ADV in single prints. The 3-day buy-side rate is an extraordinary 83.8% with a 4.4x call/put ratio. Option volume is running at 4.1x the 20-day average. Technicals: RSI at 59 (not overbought), ADX of 33 (strong trend), full bullish MA stack, up +24.43% over 1 month. The stock is running hard but has 15% runway to its 52-week high, and has gained +74% over the 200-day SMA -- momentum is intact. Catalyst: The fundamental story underpins all of this. CMPS has TWO successful Phase 3 trials for its psilocybin therapy COMP360 for treatment-resistant depression. In April 2026, the FDA granted a rolling NDA review and a Commissioner's National Priority Voucher (CNPV). Final NDA submission is targeted for Q4 2026 with an FDA decision possible in late 2026 or early 2027. The Trump executive order on psychedelic therapies has further accelerated the regulatory path. Earnings due ~Jul 30. (Compass Pathways Achieves Phase 3 Primary Endpoint) (FDA Grants NDA Rolling Review) Note: IV is 99% (1M ATM), so buying calls outright is expensive. Spreads or call diagonals to Jan 2027 would be the cleaner expression. - #2 BRKR (Bruker Corporation) bullish The Technical Momentum Play | Rating: MEDIUM-HIGH Flow: The past 3 days showed 647 calls traded vs literally 0 puts -- the cleanest directional call-only flow of any name in the screen. Block buy rate is 79% with 3 institutional-size blocks confirmed. Option volume running at 2.97x ADV -- institutions are actively building call exposure. Technicals: ADX of 39 is the strongest trend-strength reading of all three picks -- this stock is trending hard. RSI 62, bullish MA stack, up +34.37% in the past month alone after rallying from ~$42-45 late May to the high $50s. Still 11.3% below the 52-week high of $64.54, meaning there is room. The stock sits 37% above its 200-day SMA -- confirming a regime change, not just a bounce. Catalyst: Bruker's rally was triggered by semiconductor process-control exposure -- a Jefferies investor day focus on BRKR's nano-tools role in semi capex. The company expanded its infectious disease diagnostics in early June, filed a shelf registration for capital flexibility, and has earnings on August 4. Execution on cost savings and portfolio expansion is the near-term driver. (Bruker BRKR Diagnostics & Shelf Registration Analysis) Risk: IV at the 77th percentile -- elevated. Mean-reversion signal is "SELL" suggesting institutions may take some chips off near-term after the +34% surge. The VRP is negative (-6.53) meaning realized vol is actually OUTPACING implied -- a sign of how strongly this has moved. Prefer defined-risk call spreads heading into August earnings. - #3 VRNS (Varonis Systems) bullish The AI Data Security Accumulation Play | Rating: MEDIUM Flow: The 3-day call/put ratio is an astonishing 23x (1,615 calls vs only 69 puts over 3 days). One of the most extreme call-skewed flow signatures in the screen. Buy percentage is 59.2% on the call side. Small-to-mid size prints rather than massive blocks, suggesting systematic accumulation rather than a single institution. Technicals: RSI 60 (healthy, not stretched), ADX 35, trend confirmed as uptrend, momentum bullish. MA alignment is "mixed" (slight caveat -- the stock is -5.2% below its 200-day SMA, meaning it is not yet in a full bullish stack). The 1M return of +12.13% shows the rally is already underway. The stock is -47.8% below its 52-week high -- highest upside potential of the three, but also signals this is a recovery-mode name. Catalyst: VRNS posted a massive Q1 2026 beat -- revenue of $173.1M (+26.9% YoY), raised full-year guidance to ~$734M, completed a $150M buyback. Rosenblatt initiated Buy at $40 (target implies ~21% upside from current ~$32.91). Wells Fargo reaffirmed Buy on June 15. The AI-driven data security tailwind is accelerating. Earnings due ~Jul 28. (Varonis Q1 2026 Beat & Rally) (Rosenblatt Initiates Buy) Note: Option volume is below the 20-day average at 0.6x the flow is directionally clean but not massive in size. Lower conviction than CMPS or BRKR on pure flow, but the fundamental/analyst combo is strong. - Risk Flags for All Three All three have earnings within 26-30 days -- IV will ramp into those events, which can help long call holders, but also means theta drag accelerates and event risk is real CMPS has the highest standalone IV (99%) -- option buyers are paying up significantly BRKR's mean-reversion signal is the one caution on an otherwise clean setup These are not large-cap names -- position sizing and liquidity management matter
1
1
375